NERM
AVNS

New England Research & Management’s Avanos Medical AVNS Stock Holding History

New England Research & Management’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-13,207
Closed -$488K – 159
2016
Q4 		$488K Sell
13,207
-4,450
-25% -$159K 0.38% 91
2016
Q3 		$612K Buy
17,657
+4,200
+31% +$147K 0.51% 70
2016
Q2 		$438K Sell
13,457
-750
-5% -$23K 0.38% 89
2016
Q1 		$408K Buy
14,207
+1,069
+8% +$28.5K 0.35% 99
2015
Q4 		$439K Sell
13,138
-4,169
-24% -$130K 0.38% 91
2015
Q3 		$492K Buy
17,307
+3,975
+30% +$139K 0.47% 78
2015
Q2 		$540K Buy
+13,332
New +$598K 0.44% 90

Other funds holding AVNS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
PIM
Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return
SCM
Shapiro Capital Management Atlanta, Georgia $1.6B AUM 13.27% 1-Year Est. Return
PAM
Panagora Asset Management Boston, Massachusetts $26.7B AUM 36.4% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

New England Research & Management's AVNS Position: Q1 2017 in Review

New England Research & Management sold out of Avanos Medical (AVNS) in Q1 2017, closing a stake of 13,207 shares — an estimated $488K sold.

New England Research & Management first reported a position in AVNS in Q2 2015 and held it in 7 quarters. The position peaked at $612K in Q3 2016. 335 funds tracked by Wall St. Rank hold AVNS as of Q1 2017.

  • New England Research & Management reported no remaining Avanos Medical position as of Q1 2017 after selling out during the quarter.
  • New England Research & Management sold 13,207 Avanos Medical shares in Q1 2017, an estimated $488K.
  • New England Research & Management first reported a position in Avanos Medical in Q2 2015 and held it in 7 quarters.
  • New England Research & Management's Avanos Medical position peaked at $612K in Q3 2016.
  • 335 funds tracked by Wall St. Rank held Avanos Medical as of Q1 2017.

Based on New England Research & Management's 13F filing for Q1 2017, filed 7 Apr 2017.